| Personalised cancer medicine: Future crafting in the genomic era A Kerr, C Key Chekar, E Ross, J Swallow, S Cunningham-Burley Manchester University Press, 2021 | 52 | 2021 |
| Genomic research and the cancer clinic: uncertainty and expectations in professional accounts A Kerr, J Swallow, CK Chekar, S Cunningham-Burley New Genetics and Society 38 (2), 222-239, 2019 | 38 | 2019 |
| Expectant futures and an early diagnosis of Alzheimer's disease: Knowing and its consequences J Swallow Social Science & Medicine 184, 57-64, 2017 | 38 | 2017 |
| Constructing classification boundaries in the memory clinic: negotiating risk and uncertainty in constituting mild cognitive impairment J Swallow Sociology of Health & Illness 42, 99-113, 2020 | 21 | 2020 |
| Fear and anxiety: Affects, emotions and care practices in the memory clinic J Swallow, A Hillman Social Studies of Science 49 (2), 227-244, 2019 | 21 | 2019 |
| Accomplishing an adaptive clinical trial for cancer: Valuation practices and care work across the laboratory and the clinic J Swallow, A Kerr, CK Chekar, S Cunningham-Burley Social Science & Medicine 252, 112949, 2020 | 15 | 2020 |
| Online accounts of gene expression profiling in early‐stage breast cancer: Interpreting genomic testing for chemotherapy decision making E Ross, J Swallow, A Kerr, S Cunningham‐Burley Health Expectations 22 (1), 74-82, 2019 | 13 | 2019 |
| Understanding cognitive screening tools: Navigating uncertainty in everyday clinical practice J Swallow Emerging Technologies for Diagnosing Alzheimer's Disease: Innovating with …, 2016 | 11 | 2016 |
| Diagnostic layering: Patient accounts of breast cancer classification in the molecular era E Ross, J Swallow, A Kerr, CK Chekar, S Cunningham-Burley Social Science & Medicine 278, 113965, 2021 | 9 | 2021 |
| Markers of biology and “being”: imaginaries of deterioration and the biological redefinition of Alzheimer's disease J Swallow New Genetics and Society 39 (1), 13-30, 2020 | 6 | 2020 |
| Accessing targeted therapies for cancer: self and collective advocacy alongside and beyond mainstream cancer charities A Kerr, CK Chekar, J Swallow, E Ross, S Cunningham-Burley New Genetics and Society 40 (1), 112-131, 2021 | 5 | 2021 |
| Cancer, COVID-19, and the need for critique C Greco, I Arteaga, C Fabian-Therond, H Llewellyn, J Swallow, W Viney Wellcome open research 5, 2020 | 5 | 2020 |
| Enrolling the body as active agent in cancer treatment: Tracing immunotherapy metaphors and materialities J Swallow Social Studies of Science 54 (2), 305-321, 2024 | 3 | 2024 |
| (Dis) continuities in cancer care: An ethnographic approximation to practices of disease stratification I Arteaga, C Greco, H Llewellyn, E Ross, J Swallow | 3 | 2019 |
| Imagining Life with “Immunity Passports”: Managing Risk during a Pandemic G De Togni, N Boydell, S Chan, S Erikainen, A Ford, A Ganguli-Mitra, ... | 2 | 2020 |
| How and why to use ‘vulnerability’: an interdisciplinary analysis of disease risk, indeterminacy and normality A Ford, G De Togni, S Erikainen, AM Filipe, M Pickersgill, S Sturdy, ... Medical humanities 50 (1), 125-134, 2024 | 1 | 2024 |
| Unsettling the treatment imperative? Chemotherapy decision‐making in the wake of genomic techniques E Ross, A Kerr, J Swallow, CK Chekar, S Cunningham‐Burley Sociology of Health & Illness 45 (5), 1063-1081, 2023 | 1 | 2023 |
| Translations and transformations in patienthood: cancer in the post-genomics era CK Chekar, A Kerr, J Swallow University of Leeds, 2022 | 1 | 2022 |
| The Role of Instruments for Screening Cognitive Function and Alzheimer's Disease: A Sociological Exploration JE Swallow University of Leeds, 2015 | 1 | 2015 |
| The Immune System, Immunity and Immune Logics: Troubling Fixed Boundaries and (Re) conceptualizing Relations A Ford, J Swallow Medicine anthropology theory 11 (1), 2024 | | 2024 |
